Insights
Featured Carousel
- Corporate Trends and Financing
- Hot Topics: AI and ESG
- Regulatory Developments; Litigation and Enforcement
- The Nucleus: Life Sciences Enforcement and Regulatory Updates
Topics Panel Section
Managing Deal Risks in a Challenging Regulatory Environment: Strategies and Deal Terms
With antitrust and other regulators scrutinizing mergers more closely, it is crucial for companies to negotiate terms to mitigate and allocate the risk that a deal is delayed or terminated. Well-established deal provisions can be utilized.
The US Government Is Using AI To Detect Potential Wrongdoing, and Companies Should Too
With agencies such as the SEC and DOJ using AI and other data analytics tools extensively to detect wrongdoing, companies need to adopt the new technology to identify high-risk activities and spot possible misconduct.
With antitrust and other regulators scrutinizing mergers more closely, it is crucial for companies to negotiate terms to mitigate and allocate the risk that a deal is delayed or terminated. Well-established deal provisions can be utilized.
With agencies such as the SEC and DOJ using AI and other data analytics tools extensively to detect wrongdoing, companies need to adopt the new technology to identify high-risk activities and spot possible misconduct.
HKEx Moves Forward With Diversity, Climate and Sustainability Initiatives
Three Unfolding Cases Could Shape Future Energy Litigation, and Perhaps Business Practices
Latest From Skadden
-
Antitrust in Life Sciences: A Dialogue With Anna VernetApril 17, 2024
-
Seventh Circuit Decision Outlines Framework To Allow Courts To Evaluate Individual Mootness Fees in Merger Challenge LawsuitsApril 16, 2024
-
Data Protection Rulings by European Regulators Offer Insights Into Their Security ExpectationsApril 15, 2024